Whole Shine Medical Technology Balance Sheet Health
Financial Health criteria checks 3/6
Whole Shine Medical Technology has a total shareholder equity of CN¥463.8M and total debt of CN¥333.5M, which brings its debt-to-equity ratio to 71.9%. Its total assets and total liabilities are CN¥1.5B and CN¥1.1B respectively. Whole Shine Medical Technology's EBIT is CN¥67.4M making its interest coverage ratio 2.5. It has cash and short-term investments of CN¥120.0M.
Key information
71.9%
Debt to equity ratio
CN¥333.54m
Debt
Interest coverage ratio | 2.5x |
Cash | CN¥120.02m |
Equity | CN¥463.78m |
Total liabilities | CN¥1.06b |
Total assets | CN¥1.52b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002622's short term assets (CN¥289.7M) do not cover its short term liabilities (CN¥893.9M).
Long Term Liabilities: 002622's short term assets (CN¥289.7M) exceed its long term liabilities (CN¥166.9M).
Debt to Equity History and Analysis
Debt Level: 002622's net debt to equity ratio (46%) is considered high.
Reducing Debt: 002622's debt to equity ratio has increased from 30.3% to 71.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 002622 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 002622 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 41.5% per year.